Development, validation, and feasibility of a generic yoga-based intervention for Generalized Anxiety Disorder.

Development Generalized anxiety disorder Validation Yoga intervention

Journal

Complementary therapies in medicine
ISSN: 1873-6963
Titre abrégé: Complement Ther Med
Pays: Scotland
ID NLM: 9308777

Informations de publication

Date de publication:
Dec 2021
Historique:
received: 04 06 2020
revised: 18 09 2021
accepted: 20 09 2021
pubmed: 28 9 2021
medline: 17 12 2021
entrez: 27 9 2021
Statut: ppublish

Résumé

Evidence suggests that yoga effectively manages anxiety, but techniques are derived from different yoga schools. This paper describes the development, validation, and feasibility of a generic yoga-based intervention in patients with Generalized Anxiety Disorder (GAD). The first part of the study consisted of designing a generic yoga module from the traditional and contemporary yogic literature and inputs from ten experienced yoga practitioners. The content was validated using a case-vignette method from 28 yoga experts. These yoga experts rated the usefulness of the practices on a scale of 1-5 (5-extremely useful). The second part consisted of testing the feasibility of this validated generic yoga intervention in an open-label clinical trial in patients with GAD. Two weeks of ten supervised yoga sessions (SYS) were offered by a trained yoga therapist to the recruited participants and subsequently advised for home practice. A weekly booster SYS was also provided for three months after 10SYS. Yoga experts (n = 28) opined that the yoga intervention would be helpful in patients with GAD with minimal modifications. All experts opined that the module was easy to teach, learn and practice. The final yoga module retained 97.7% (42 out of 43) items of the initial module. In the feasibility study, (n = 20) patients were recruited, and fifteen followed-up after one month. All patients were able to learn and practice the final yoga module within ten sessions without any significant adverse effects. The severity of anxiety reduced substantially after the ten days of SYS and this improvement was sustained for the next 4 weeks. The designed generic yoga intervention was validated by yoga experts and found safe and feasible in patients with GAD. Patients obtained significant symptom reductions which need to be confirmed in randomized controlled trials.

Identifiants

pubmed: 34571143
pii: S0965-2299(21)00117-5
doi: 10.1016/j.ctim.2021.102776
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

102776

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.

Auteurs

Pooja More (P)

Department of Integrative Medicine, National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, India. Electronic address: drpoojamore001@gmail.com.

Vinod Kumar (V)

Department of Integrative Medicine, National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, India. Electronic address: vinoddrvinod@gmail.com.

M R Usha Rani (MR)

Department of Integrative Medicine, National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, India. Electronic address: ushaayog@gmail.com.

Mariamma Philip (M)

Department of Biostatistics, National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, India. Electronic address: dr.mariammaphilip@gmail.com.

Narayana Manjunatha (N)

Department of Psychiatry, National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, India. Electronic address: manjunatha.adc@gmail.com.

Shivarama Varambally (S)

Department of Integrative Medicine, National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, India; Department of Psychiatry, National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, India. Electronic address: drvarambally@gmail.com.

Bangalore N Gangadhar (BN)

Department of Psychiatry, National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, India. Electronic address: kalyanybg@yahoo.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH